Thus, HIF-1 represents a promising target for clinical interventions reducing cancer occurrence and suppressing tumor development; these interventions may regulate its expression, modulate protein synthesis, affect protein dimerization, or decrease the ability of HIF-1 to bind to its target DNA sequences. This evidence concerns the gene HIF1A and neoplasm.